310 related articles for article (PubMed ID: 28432265)
1. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
[TBL] [Abstract][Full Text] [Related]
2. A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.
Guekht A; Skoog I; Korczyn AD; Zakharov V; Eeg M; Vigonius U
Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):459-67. PubMed ID: 24516413
[TBL] [Abstract][Full Text] [Related]
3. Remote Ischemic Post-Conditioning may Improve Post-Stroke Cognitive Impairment: A Pilot Single Center Randomized Controlled Trial.
Li YJ; Liang KK; Zhang L; Pan R; Hu YM; Zhao JH
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105217. PubMed ID: 33066895
[TBL] [Abstract][Full Text] [Related]
4. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
5. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
[TBL] [Abstract][Full Text] [Related]
6. Modafinil May Alleviate Poststroke Fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial.
Poulsen MB; Damgaard B; Zerahn B; Overgaard K; Rasmussen RS
Stroke; 2015 Dec; 46(12):3470-7. PubMed ID: 26534969
[TBL] [Abstract][Full Text] [Related]
7. Actovegin in the management of patients after ischemic stroke: A systematic review.
la Fleur P; Baizhaxynova A; Reynen E; Kaunelis D; Galiyeva D
PLoS One; 2022; 17(6):e0270497. PubMed ID: 35771887
[TBL] [Abstract][Full Text] [Related]
8. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
9. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
Semlitsch HV; Anderer P; Saletu B; Hochmayer I
Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
Mikhaĭlova NM; Selezneva ND; Kalyn IaB; Roshchina IF; Gavrilova SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):69-76. PubMed ID: 23994934
[TBL] [Abstract][Full Text] [Related]
11. Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics.
Brainin M; Matz K; Nemec M; Teuschl Y; Dachenhausen A; Asenbaum-Nan S; Bancher C; Kepplinger B; Oberndorfer S; Pinter M; Schnider P; Tuomilehto J;
Int J Stroke; 2015 Jun; 10(4):627-35. PubMed ID: 24206541
[TBL] [Abstract][Full Text] [Related]
12. PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.
de Ridder IR; den Hertog HM; van Gemert HM; Schreuder AH; Ruitenberg A; Maasland EL; Saxena R; van Tuijl JH; Jansen BP; Van den Berg-Vos RM; Vermeij F; Koudstaal PJ; Kappelle LJ; Algra A; van der Worp HB; Dippel DW;
Stroke; 2017 Apr; 48(4):977-982. PubMed ID: 28289240
[TBL] [Abstract][Full Text] [Related]
13. Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial.
Matz K; Teuschl Y; Firlinger B; Dachenhausen A; Keindl M; Seyfang L; Tuomilehto J; Brainin M;
Stroke; 2015 Oct; 46(10):2874-80. PubMed ID: 26374482
[TBL] [Abstract][Full Text] [Related]
14. Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke).
Amaro S; Laredo C; Renú A; Llull L; Rudilosso S; Obach V; Urra X; Planas AM; Chamorro Á;
Stroke; 2016 Nov; 47(11):2874-2876. PubMed ID: 27758945
[TBL] [Abstract][Full Text] [Related]
15. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China.
Zhang S; Wu B; Liu M; Li N; Zeng X; Liu H; Yang Q; Han Z; Rao P; Wang D;
Stroke; 2015 May; 46(5):1301-6. PubMed ID: 25873601
[TBL] [Abstract][Full Text] [Related]
17. Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
Weintraub D; Hauser RA; Elm JJ; Pagan F; Davis MD; Choudhry A;
Mov Disord; 2016 May; 31(5):709-14. PubMed ID: 27030249
[TBL] [Abstract][Full Text] [Related]
18. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.
Bivard A; Lillicrap T; Krishnamurthy V; Holliday E; Attia J; Pagram H; Nilsson M; Parsons M; Levi CR
Stroke; 2017 May; 48(5):1293-1298. PubMed ID: 28404841
[TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.
Ziegler D; Movsesyan L; Mankovsky B; Gurieva I; Abylaiuly Z; Strokov I
Diabetes Care; 2009 Aug; 32(8):1479-84. PubMed ID: 19470838
[TBL] [Abstract][Full Text] [Related]
20. Effects of Blood Pressure in the Early Phase of Ischemic Stroke and Stroke Subtype on Poststroke Cognitive Impairment.
He M; Wang J; Liu N; Xiao X; Geng S; Meng P; Ji N; Sun Y; Xu B; Xu Y; Zhou X; Zhang G; He X; Cai Z; Li Z; Wang B; Xu B; Hui R; Wang Y
Stroke; 2018 Jul; 49(7):1610-1617. PubMed ID: 29895539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
